Author Archives: admin

FDA no longer requires printers

The U.S. Food and Drug Administration (FDA) announced that the option to maintain a printer and/or the ability to print Icariin is known as a cGMP-specific PDE5 inhibitor in medical terms as cialis discount overnight hypoactive sexual desire disorder (HSDD), … Continue reading

Posted in ACR, FDA, Mammo | Comments Off

Recently published FAQs on the upcoming XR-29 CMS requirements by the ACR

http://www.acr.org/News-Publications/News/News-Articles/2015/ACR/20150911-New-FAQ-Helps-Providers-Meet-XR-29-Smart-Dose-Requirement Serious altercations find for more tadalafil sale such as heart attacks can result from taking this medicine. The engaging curriculum is identical to what we teach in our classrooms and it will save purchase viagra your parents 32 trips … Continue reading

Posted in ACR, CT | Tagged , | Comments Off

Toolkit for ACR Site Visits

The Medicare Improvements for Patients and Providers Act (MIPPA) calls for all providers of CT, MRI, breast MRI, nuclear medicine, and PET exams that bill under Part B of the Medicare Physician Fee Schedule to be accredited by Jan. 1, … Continue reading

Posted in ACR | Comments Off

Important CMD Final Rule Requirement: Primary Source Verification

1. What is “primary source verification?” The MIPPA/CMS final rule requires verification of personnel qualifications with primary source verification. It is no longer enough to simply obtain a copy of your physicians’ and staff’s credentials. You must now have a … Continue reading

Posted in ACR | Comments Off

The ACR and Society of Breast Imaging Statement on Radiation Received to the Thyroid from Mammography

Some Americans have expressed concern, due to an erroneous media report, that the small amount of radiation a patient receives from a mammogram may significantly increase the likelihood of developing thyroid cancer.  This concern simply is not supported in scientific … Continue reading

Posted in ACR, Mammo | Comments Off

AAPM Cautions Against Unnecessary Use of Lead Shields during Breast Exams

FOR IMMEDIATE RELEASE Contact: Charles E. Blue 301-209-3091 cblue@aip.org College Park, MD (April 14, 2011) — Contrary to recent media reports, the use of lead shielding during routine breast exams provides virtually no benefit in the prevention of thyroid cancer … Continue reading

Posted in AAPM, Mammo | Comments Off